These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity. Gillespie MN; Olson JW; Hennig B; Cohen DA; McClain CJ; Goldblum SE Toxicol Appl Pharmacol; 1989 Mar; 98(1):134-43. PubMed ID: 2494779 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension. Kay JM; Keane PM; Suyama KL; Gauthier D Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933 [TBL] [Abstract][Full Text] [Related]
10. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension. Orlinska U; Olson JW; Gillespie MN Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of deoxyribonucleic acid synthesis by difluoromethylornithine. Role of polyamine metabolism in monocrotaline-induced pulmonary hypertension. Hacker AD Biochem Pharmacol; 1992 Sep; 44(5):965-71. PubMed ID: 1530663 [TBL] [Abstract][Full Text] [Related]
12. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension induced in rats by monocrotaline and chronic hypoxia is reduced by p-chlorophenylalanine. Kay JM; Keane PM; Suyama KL Respiration; 1985; 47(1):48-56. PubMed ID: 3156395 [TBL] [Abstract][Full Text] [Related]
15. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole. Schultze AE; Emeis JJ; Roth RA Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888 [TBL] [Abstract][Full Text] [Related]
16. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS. Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805 [TBL] [Abstract][Full Text] [Related]